Background. CD157, a cell surface molecule belonging to the ADP-ribosyl cyclase family,
Introduction
Ovarian carcinoma is among the most lethal of gynecological malignancies and has an extremely poor prognosis (1) . This is primarily due to the inability to detect the tumor at an early stage (2), consequently, most patients are diagnosed at an advanced stage of disease when the tumor has spread throughout the peritoneum.
The majority of OvCa arise from the surface epithelium which overlies the ovary and lines postovulatory inclusion cysts (3) . OvCa may spread by direct extension to adjacent organs, and malignant cells may exfoliate and be transported by normal peritoneal fluid as multi-cellular aggregates or spheroids (4) . Discrete steps of the implant of the tumor are its adhesion to mesothelial cells, migration throughout and invasion of the omentum and peritoneum (5, 6) .
Seeding into the peritoneal cavity is frequently associated with ascites formation. Dissemination of OvCa through the vasculature is generally rare, although the presence of metastases in extraperitoneal sites (e.g., bone marrow, brain and liver) has been described in advanced-stage disease (7, 8) .
The mesothelium, a single layer of cells covering the peritoneal cavity and its organs, is the first barrier encountered by OvCa cells and the major site of tumor dissemination. Mesothelial cells release different inflammatory mediators, ECM proteins, adhesion molecules and chemotactic factors that foster peritoneal metastases (9, 10) . The development of peritoneal metastases is regulated by a set of interacting molecules expressed by the tumor and/or mesothelium and occurs in sequential steps (5, 11) . The molecular mechanisms that control invasion into the surrounding stroma and dissemination to the peritoneum are still unidentified.
It is known that dissemination of tumor cells shares several steps with leukocyte extravasation, a physiological process in which ectoenzymes play important roles (12) . One of these ectoenzymes is CD157, a glycosylphosphatidylinositol (GPI)-anchored glycoprotein encoded by a member of the NADase/adenosine diphosphate (ADP)-ribosyl cyclase gene family which also encodes CD38 (13, 14) . Although initially characterized as a stromal (15) and myeloid surface antigen (16) , CD157 is also expressed by other selected cell types (17) , including vascular endothelial cells (18) and mesothelial cells (19) . It is involved in a number of cellular functions (20) (21) (22) and participates in signal transduction through interactions with transmembrane partner molecules (23, 24) . Evidence indicates that CD157 is a key molecule in the control of leukocyte adhesion and migration, acting both on leukocytes and endothelial cells (18, 25) .
The expression of CD157 by mesothelial cells (19) , which share biological properties and embryonic origin with ovarian surface epithelial cells, led us to hypothesize that it might be also expressed by epithelial OvCa cells and involved in interactions between the mesothelium and tumor cells, ultimately controlling OvCa dissemination.
The results obtained confirmed the working hypothesis, indicating that CD157 i) is expressed by epithelial OvCa, both in tissues and primary cell cultures and cell lines, as well as by primary peritoneal mesothelial cells. Furthermore, it ii) controls OvCa cell migration and invasion on matrigel, fibronectin, laminin and collagen and, iii) regulates peritoneal dissemination and mesothelial invasion of serous epithelial OvCa cells in vitro. The results obtained in vitro are confirmed in vivo, where iv) CD157 is a prognostic factor for tumor recurrence in OvCa and a powerful predictive variable for disease recurrence and survival in the serous histotype.
Methods

Antibodies and reagents.
The anti-CD157 (SY/11B5, IgG1) (26) , anti-β1 integrin/CD29 (Moon-4, IgG1) monoclonal antibodies (mAb) and irrelevant murine monoclonal IgG (mIgG) (produced in-house) were affinity purified on protein G (Sigma-Aldrich). RF3 (anti-CD157, IgG2a) mAb was from MBL International (Milan, Italy). Affinity purified, F(ab') 2 Three primary human peritoneal mesothelial cell (HPMC) cultures were used for the present study. HPMC 2293 was derived from the peritoneal washing of a patient with a mature ovarian teratoma, HPMC 3361 and HPMC 7916 from the peritoneal washing of patients with endometrioid cystadenoma of the ovary. All samples were free of tumor cells, as determined by cytological analysis of cytospin preparations, and contained high percentages of mesothelial cells. HPMC were isolated as described in (5) . The mesothelial origin of the cells was verified by vimentin, cytokeratin 8 and calretinin positivity and CD31 negativity (data not shown). HPMC at early passages (1-4) were used for the experiments to minimize dedifferentiation and modifications of the original phenotype.
Reverse transcription-PCR analysis.
Total RNA was purified from ~1 x 10 6 cells using the TRI Reagent (Sigma-Aldrich), and cDNA transcribed from total RNA (2-5 µg) using SuperScript II RT (Invitrogen), according to the manufacturer's instructions. The primers used were as follows: CD157, 5'-GAGATATCCGAGCGAGAG-3' (sense) and 5'-GGACATCGTTTTCCCAG-3'(antisense); β-actin, 5'-CCAAGGCCAAACCGCGAGAAGATGAC-3' (sense) and 5'-AGGGTACATGGTGGTGCCGCCAGAC-3'(antisense).
The PCR reaction conditions for CD157 were: 49 cycles of 30 seconds denaturation at 95 °C, 1 minute (min) annealing at 55 °C, 90 seconds extension at 72 °C. The PCR reaction conditions for β-actin housekeeping gene were: 30 cycles of 1 min denaturation at 94 °C and 2 min annealing at polymerized at 37 °C for 1 hour (h) and equilibrated in serum-free medium. OvCa cells were suspended (10 5 cells/well) in medium with 1% FCS, treated with the indicated mAb (10 μg/ml) for 20 min, and then seeded on the coated filters. Medium containing 10% FCS was added to the lower chamber as the chemoattractant. After 16 h incubation at 37 °C, non-invading cells in the upper chamber were removed with a cotton swab and the filters were fixed with methanol and stained with hematoxylin-eosin. The membranes were mounted and migrated cells were photographed at low magnification (x10). Migrated cells were counted in 8 different mediumpower fields for each filter.
Adhesion to ECM proteins assay.
OvCa cells (4x10 4 /well) pre-treated or not with selected mAb (10 µg/ml) for 20 min were plated in 96-well plates coated with FN, Coll I (both at 10 µg/ml) or LN (5 µg/cm 2 ). After 1 h at 37 °C, non-adherent cells were removed, adherent cells were fixed with 4% PFA and stained with 0.5% crystal violet for 15 min. After cell lysis with 2% SDS, the absorbance was measured at 595 nm.
Each adhesion assay was carried out in quadruplicate and repeated at least twice. Results are expressed as a percentage of adhesion of the mIgG-treated control.
Wound assay.
Wounds were created in confluent OvCa cells using a pipette tip. The cells were then rinsed to remove debris, and medium with 1% FCS was added. Wound healing was observed at 0 and 24 h within the scraped line. Duplicate wells of each condition were examined for each experiment, and experiments were repeated 3 times. Quantitative analysis of the percentage of wound healing was calculated by measuring 20 randomly chosen distances across the wound at time 0 and 24 h, divided by the distance measured at time 0. Images were acquired using the Olympus Biosystems Microscope BX71, equipped with the F-View II camera and the AnalySIS FIVE analysis software (Olympus Biosystems, Hamburg, Germany).
Spheroid formation.
Spheroids were generated using a modification of the hanging droplet method (27) . Briefly, cells (5x10 2 /15 μl of RPMI with 10% FCS) were placed on the cover of a tissue culture dish. The cover was placed over a dish containing 10 ml of PBS to prevent dehydration of the hanging droplets.
Spheroid formation was monitored after 4 days.
Spheroid dissemination and mesothelial monolayer invasion assay.
HPMC (1x10 4 /well) were grown until confluence on 96-well plates. Spheroids (5-10/well) were seeded onto the HPMC monolayer in the constant presence of the indicated mAb (10 μg/ml).
Every 24 h, two thirds of the medium was replaced with fresh medium containing the indicated mAb. Spheroids were digitally photographed 1 h after plating (t = 0) and again at 1, 3, and 7 days.
Spheroid dissemination was defined as spheroid disaggregation and spreading on top of the HPMC monolayers without forming invasive foci and quantified by calculating the fold change in area (spheroid pixel area at each time point/spheroid pixel area at t = 0). Spheroid invasion was defined as described (28) . The percentage of invasion was quantified by counting the invading spheroids: 80-100 spheroids were counted for each experimental condition, from two experiments.
Images were acquired using the Olympus Biosystems Microscope BX71, equipped with the FView II camera and the AnalySIS FIVE software (Olympus Biosystems).
Spheroid disaggregation assay.
The disaggregation assay was performed as previously described (29) . Briefly, 96-well plates coated with 10 μg/ml FN and Coll I or 5 µg/cm 2 LN were blocked with BSA (1 mg/ml) for 1 h at 37 °C. Spheroids (5-10 spheroids/well) were seeded on wells in serum-free RPMI 1640 medium.
After 30 min at 37 °C, the indicated mAb (10 µg/ml) were added. To track individual spheroids over time, a map of the wells was created. The pixel area of the spheroids at each time points was measured, and the fold change in area was calculated as the ratio between the pixel area of the spheroids at 24 h and at time 0. Results represent the average fold change in area of 50-90 spheroids for each condition.
Adhesion to HPMC assay. The histological type and the grade of tumors were determined by WHO criteria. Follow-up data, including overall survival and disease recurrence, were available for all patients. The median follow-up period calculated from the date of surgery, was 50 months (range, 1-140 months). The
Institutional Review Boards approved the use of tissue samples and patients records.
Immunohistochemistry.
CD157 localization was examined on tissue sections (5 μm) from formalin-fixed, paraffinembedded epithelial OvCa following antigen retrieval in 10 mM citrate buffer (pH 7.5) at 125 °C respectively. The DFS and OS were analysed using the Kaplan-Meier curves, and differences in survival between the groups of patients were assessed using the log-rank test.
Univariate and multivariate survival analysis was performed for all available clinicopathologic variables, including the CD157 H-score, using the Cox proportional hazards regression model.
Covariate that were not statistically significantly associated with survival were not removed from the model (complete model). Proportional hazard (PH) assumption was checked using the 
Results
CD157 expression in human epithelial ovarian cancer and peritoneal mesothelial cells.
Expression of CD157 was first investigated in fresh samples of ovarian tumors. Surgical specimens of epithelial OvCa were obtained from 6 chemotherapy-naive patients (Table 1) These experiments demonstrated that i) the invasive potential varies from tumor to tumor, at least in the experimental conditions adopted here; ii) ligation of CD157 caused a significant mg/ml, data not shown). As expected (29, 35) , spheroid disaggregation on all the ECM considered was strictly dependent on β1 integrin (P < .001, Figure 5 , E).
CD157 expression and clinicopathological characteristics of human ovarian cancer.
The results of the present work provide compelling evidence that CD157 plays a significant role in migration and dissemination of serous OvCa. The validity of the findings observed in vitro was assessed in vivo by analyzing the characteristics of a sample of OvCa patients. A multivariable Cox proportional hazard model was used to test the influence on survival of all the available clinicopathologic variables, including CD157 H-score. This analysis revealed that in addition to the tumor stage (HR = 3.489, 95% CI = 1.531 to 7.949, P = .003) and histological type (non serous vs serous; HR = 2.139, 95% CI = 1.128 to 4.055, P = .020), CD157 H-score was also an independent prognostic factor for DFS in ovarian carcinoma. Patients with CD157 H-score ≥60 had a statistically significant higher risk of tumor recurrence than patients with CD157 H-score <60 (HR = 2.438, 95% CI = 1.247 to 4.764, P = .009) ( Table 3, A) .
Multivariable analysis performed on serous carcinoma confirmed that CD157 is an independent prognostic factor of tumor relapse (HR = 3.008, 95% CI =1.351 to 6.694, P = .007) ( Table 3, A) and overall survival (HR = 3.443, 95% CI = 1.273 to 9.308; P = .015) ( Table 3 , B).
Discussion
CD157 controls leukocyte diapedesis in inflammatory conditions (18, 22) , a physiological process similar to that exploited by tumor cells to migrate to secondary sites. We hypothesized that the role of CD157 might extend beyond that of controlling leukocyte trafficking to include more general regulation of cellular invasive and migratory activities, including cancer cell dissemination. The model adopted to test the validity of our hypothesis was dissemination in ovarian carcinoma. The choice was also independently sustained by a recent study showing that BST-1/CD157 is one of the genes differentially expressed by primary cultures of normal ovarian surface epithelia and epithelial OvCa cells (36).
The results of this study provide evidence that CD157 is expressed by epithelial OvCa New experimental approaches based on antibody-directed therapy and intraperitoneal injection have furnished promising new strategies for the treatment of OvCa dissemination (45, 46) . It is tempting to predict that CD157 may serve as a novel target for therapies in the control of invasion and dissemination of the peritoneal cavity by serous OvCa cells after surgical debulking.
Study limitations
The role of CD157 in the control of peritoneal dissemination and invasion of ovarian cancer was studied using in vitro models that may not thoroughly represent the situation in vivo. Results from in vivo animal models will allow more definitive conclusions to be drawn. 
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